Masayuki Hino

Discontinuation of dasatinib in patients with chronic myeloid leukaemia who have maintained deep molecular response for longer than 1 year (DADI trial): a multicentre phase 2 trial

Jun Imagawa, Hideo Tanaka, Masaya Okada et al. · The Lancet Haematology · 2015 · 297 citations

Hematological Malignancy, Medicine, Chronic Myeloid Leukaemia +11

Transmission of symptomatic parvovirus B19 infection by fibrin sealant used during surgery

Masayuki Hino, Osamu Ishiko, Kenichi Honda et al. · British Journal of Haematology · 2000 · 242 citations

Notable effects of angiotensin II receptor blocker, valsartan, on acute cardiotoxic changes after standard chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisolone

Hirohisa Nakamae, Kei Tsumura, Yoshiki Terada et al. · Cancer · 2005 · 241 citations · Full text

Platelet P-Selectin Expression Is Associated With Atherosclerotic Wall Thickness in Carotid Artery in Humans

Hidenori Koyama, Takaaki Maeno, Shinya Fukumoto et al. · Circulation · 2003 · 160 citations

Cytokine-Specific Activation of Distinct Mitogen-Activated Protein Kinase Subtype Cascades in Human Neutrophils Stimulated by Granulocyte Colony-Stimulating Factor, Granulocyte-Macrophage Colony-Stimulating Factor, and Tumor Necrosis Factor-

Kenichi Suzuki, Masayuki Hino, Fumihiko Hato et al. · Blood · 1999 · 156 citations